What is the Projected CAGR value of the Spain Opioid-Induced Constipation Market ?
Spain Opioid-Induced Constipation Market is expected to grow at a CAGR of 4.4% during the forecast period 2024-2031.
Who are the key players in Spain Opioid-Induced Constipation Market ?
Major players are AstraZeneca, Shionogi & Company, Limited, Takeda Pharmaceuticals Company Ltd, and Bausch Health Companies Inc.